The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Original Article

Filter Newest Oldest Showing 61-80 of 129 results
Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Comparison of CURB-65 Pneumonia Severity Score, Quick COVID-19 Severity Index, and Brescia-COVID Respiratory Severity Scale in Emergently Hospitalized COVID-19 Patients with Pneumonia

İbrahim Toker and others

Coronavirus disease 2019 (COVID-19) occurred with different levels of severity, and different criteria for hospitalizations were suggested, considering risk factors for poor outcomes, such as advanced age, comorbidities, lymphopenia, and high C-reactive protein (CRP) levels. The most severe complication of COVID-19 is viral pneumonia, which is often manifested by diffuse bilateral lung (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey

Yeliz Tanrıverdi-Çaycı and others

Urinary tract infections (UTIs) are seen in all age groups and are among the most frequent bacterial infections. Enterobacterales are the most common bacterial species that cause UTIs . Escherichia coli is the most common cause of both complicated UTIs (65%) and uncomplicated UTIs (75%). E. coli is followed by other Enterobacterales such as Klebsiella spp., Proteus spp., and Serratia spp. Resistance of urinary tract pathogens to (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Stenotrophomonas maltophilia Bacteremia: From Diagnosis to Treatment

Pınar Aysert-Yıldız and others

Stenotrophomonas maltophilia is an aerobic, non-fermentative, Gram-negative bacterium widespread in aquatic environments and soil. It has an inherent ability to adhere to abiotic surfaces and forms biofilms. It is usually considered to be a commensal and a low-grade pathogen. However, it can cause severe infections in the immunocompromised and debilitated (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prospective Evaluation of Infections in Geriatric Patients in Intensive Care Units

Hasan Naz and others

Nosocomial infections (NIs) constitute a major health issue in terms of morbidity, high mortality, prolonged hospitalization, and increased costs of direct patient care. While beds in intensive care units (ICUs) constitute less than 10% of all hospital beds, more than 20% of all NIs develop in the ICU. The human lifespan has been prolonged (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy

Halime Araz and others

Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies to reduce bilirubin levels, improve liver functions, prolong survival and enable other treatments. The procedure is critical because of its potential complications. The most common (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Maternal Stress and Neonatal Nutrition during the COVID-19 Era

Alara Altıntaş and others

COVID-19 has been the main focus of the world since the beginning of 2020. The virus has infected over 180 million people and caused about 6 million deaths worldwide up to February of 2022. With its rapid spread, the new coronavirus posed enormous economic, environmental, and social challenges together with health threats to the entire (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

The Effect of the Pandemic on Antifungal Use: What Has Changed?

Vildan Avkan-Oğuz and others

Before coronavirus disease 2019 (COVID-19), antimicrobial stewardship (AMS) programs were essential for managing multidrug-resistant Gram-negative bacterial infections. In contrast, antifungal stewardship (AFS) programs were uncommon as a component of AMS. During the COVID-19 pandemic, both AMS and AFS programs have lost (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Cognitive Assessment of Young Adults Before and After Initiation of Combination Antiretroviral Therapy

Özlem Gül and others

The presence of cognitive disorders in the human immunodeficiency virus (HIV) infected individuals has been known for a long time. A complete neuropsychological evaluation method is a gold standard for diagnosing HIV-related cognitive impairment (HAND). However, such tests require specially trained personnel and specialized centers, and testing takes a long time. Montreal Cognitive (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Gardnerella vaginalis: Is it an Underestimated Cause of Urinary Symptoms in Males?

Mert Kılıç and others

Gardnerella vaginalis is an anaerobic, gram-negative/variable, small, pleomorphic microorganism. The jury is still out about the clinical significance of G. vaginalis. It is the predominant microorganism in women with vaginosis and also can be isolated from a vaginal secretion of 40-50% of asymptomatic women . On the other hand, male genitourinary tract infections (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Bloodstream Infections in Immunocompetent Patients

Şirin Menekşe and others

Stenotrophomonas maltophilia is a Gram-negative, non-fermentative aerobic bacterium that infects patients, especially with severe comorbidities such as hematological malignancies. It is commonly found in the environment and hospital settings. The most common clinical presentations are pneumonia and bloodstream infections (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5

Yeşim Tuyji-Tok and others

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants have been detected since the summer of 2020, and their critical association with viral load, transmissibility, and escape from the innate-vaccine immune response were demonstrated. Another new variant was identified (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Antibiotic Use among Patients Hospitalized with COVID-19 and Treated in Three Different Clinics

Oğuz Evlice and others

The clinical spectrum of COVID-19 varies, ranging from asymptomatic infection to critical illness. The most commonly used tool for the classification of disease severity is the National Institute of Health (NIH) severity scale, which has four categories: mild, moderate, severe, and critical. Patients with moderate and severe clinical courses are followed up in wards, while those with (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Factors Associated with Gram-Negative Bacteremia and Mortality in Neutropenic Patients with Hematologic Malignancies in a High-Resistance Setting

Caglayan Merve Ayaz and others

The number of patients with hematological malignancies (HMs) and those undergoing hematopoietic stem cell transplantation (HSCT) has been on rise during the last three decades. Febrile neutropenia (FN) is the most common complication in this specific patient group and requires urgent intervention. Bacteremia […] Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Necrotizing Fasciitis: Evaluation of 85 Cases and Usage of LRINEC Score

Ebru Oruç and others

Necrotizing fasciitis (NF), one of the necrotizing soft tissue infections, is an infection that primarily involves subcutaneous adipose tissue, which consists of superficial fascia, vascular and neural structures, and involves in deep fascia and progresses with mortality. It may be difficult to differentiate (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

HIV and SARS‐Cov‐2 Co-Infection: A Local Perspective

Heval Can Bilek and Aydın Deveci

In early December 2019, interstitial pneumonia of unknown origin emerged in Wuhan, the capital of China’s Hubei province. The pathogen was identified as a novel beta coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease caused by SARS-CoV-2 was later named (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial

Lütfiye Nilsun Altunal and others

Clinically COVID-19 can be observed with mild symptoms such as fever, malaise, cough, and also severe symptoms such as acute respiratory distress syndrome (ARDS) that may require respiratory support in up to 25% of the patients . COVID-19 has a high mortality rate, in hospitalized (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Nasopharyngeal Carriage and Serotype Distribution of Streptococcus pneumoniae in Elderly: A Cross-sectional Study in Turkey

Muammer Çelik and others

Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae is an important cause of morbidity and mortality among young children and adults 65 years and older. S. pneumoniae is one of the most important causes of serious diseases, such as pneumonia, meningitis, and bacteremia. According to 2018 surveillance data from US Centers for Disease (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

West Nile Virus Seroprevalence in Manisa Province: A Population-based Study

Abdurrahman Gülmez and others

West Nile Virus (WNV) is an enveloped RNA virus with icosahedral symmetry and with a size of 45-50 nm belonging to the family Flaviviridae, genus Flavivirus (1). The virus, which was first isolated from a woman living in the West Nile region of Uganda in 1937, was noted with consecutive outbreaks in North Africa (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study

Ege Anıl Uçar and others

Rational use of medicines (RUM) has been a concern worldwide for half a century, and is of great importance, given that almost half of all prescribed drugs are irrational. The irrational use of drugs can be disastrous and may cause adverse events, creating a (...) Read More